US › Healthcare

AgomAb Therapeutics NV American Depositary Shares (AGMB)

US · Healthcare · Biotechnology

$14.73+8.95%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Net profit
$-11.7M
EPS
$-0.42

Key statistics

Market cap
$633.8M
Forward P/E
0.0
P/B
4.22
Book value
$-3.95
EPS (TTM)
$-1.47
52-week high
$17.82
52-week low
$8.75
50-day MA
$11.93
200-day MA
$12.37

Analyst view

with an average price target of $33.00.

Shareholding

Insiders
5.90%
Institutions
48.73%

Largest institutional holders

FundStake
EQT Fund Management S.à r.l.10.44%
Sanofi5.65%
Cormorant Asset Management, LLC5.01%
TCG Crossover Management, LLC4.17%
Federated Hermes Inc3.29%
Casdin Capital, LLC3.15%
Andera Partners3.12%
FMR Inc2.96%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for AgomAb Therapeutics NV American Depositary Shares — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.